{"ticker": {"uuid": "e6ef0a44-e0ce-4011-89e8-ca20867db0b2", "symbol": "DMRA", "name": "Damora Therapeutics, Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "H.C. Wainwright reiterates Buy on Damora Therapeutics stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQclF3SS1sMkVCZVpTRkZLUTVjenlqQXVnM1NTaFRiYTJhbFRiNmRSdExxd2E5cFQ4SnFyZ1BNZnJoVUlydmFraFdPSVRfQlZnbHFaeldsOFcza21FcVV2cXVsZU5Eb3h6TFBIQjhJT19FaTBYcnVVVDYxRkF6T1pMc0ZKbTdmWHdIbDF0bFhVcF93YjlBSk1MY0RnTnhtbnM5WktvcmZTc29wOE1uSS1LbWpXcUc2bGM1?oc=5", "source_name": "Investing.com", "published_at": "2026-07-21T11:59:16+00:00", "published_display": "21 Jul 2026 11:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics, Inc. Common Stock (DMRA) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE5BdzA0NGc0bnVWZy1yaGxjWE02VG53ZkFXUE5xSmpWRVM1VndyVVU0SWFlVGJmOXA2dVNFOWpzcVdFOWxfaHRMQmFsNUJRNml5RU1nTlNKLVJfMEphRC12Z0U4QWM0TXJWNUZ6X1puZnlrdkk2dlE?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-19T16:26:59+00:00", "published_display": "19 Jul 2026 16:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNTUcwY1FLazBFeUZjY3dIN0JtNnBZcVdUNGhUX3RBTlBfYTJ2elBCeV9NRmw0d1lndzZWWlB6ZDMtYXlnY1FaZnRyYWRyYzVzQ3AzcF9Jd1dlU29xM3lyLWo4MlItVm4zNFc2dVVfM1JPY1FoRk52VWZVb2ZxcVpfcw?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-19T14:58:42+00:00", "published_display": "19 Jul 2026 14:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics Completes Redomestication to Cayman Islands", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/damora-therapeutics-completes-redomestication-cayman-172646630.html", "source_name": "MT Newswires", "published_at": "2026-07-17T17:26:46+00:00", "published_display": "17 Jul 2026 17:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics completes redomestication to Cayman Islands By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNNUNJbERXN3A2aUd1NGhBaEJTd0ZTNE4zeTVXQXI4dEJaU2RNTS0wTWppR1VjNGFUMGJHY1Z4RjNfN3BEY2FDdTRpT1VKbWIzQkgxX2Y0cGFuUGdpWl9FSVVudEdqQktvS0xJWUF0VVkxZ1RXRDFjY3hubWE2a1NvTXFtbXFNUF9Bckota0pUemZBeEVwbFBoTHhOaU52SVZfbW5rLUtrQ1RUMUR3OUZVaEZmMmlEdXJxYWhfMnAxLTVodw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-17T13:02:37+00:00", "published_display": "17 Jul 2026 13:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Announces Redomestication from Delaware to Cayman Islands", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-07-17T12:13:40+00:00", "published_display": "17 Jul 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Will Keep DMRA Ticker Under New Nasdaq CUSIP July 20", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQeW5iaVZadVE3Wkp3all5eUEwSlE4RGRBRzdHRmNlc1BfU2otU3lhZHp4VWtRcFV1UGc0LUxQV0JJRzlKb3diM0FxSllzVm1SbHZHZmFtb3NXRjBxX3VXeWtuT2Y0UTVFN1djU0NyTEpZbzlsZlFWLXBGQk55TzBMWWpIVXFqb1BfaUdvRHpRMkhIOVJnU2xKVTJoWDRqNG9OYm5DeUlxMUh6blE3dVNYQg?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-17T12:00:00+00:00", "published_display": "17 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Form 4 Damora Therapeutics Inc For: 7 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNMmhydlNGaDVPajJDYTZCLUNfQjNsc3ZyZU9Zb192bTZKazFtcGRIaVJRWXFQay1ERnVNNmtGbmU1Q1JTTGZTYUlXRVRlOGFuSGI5eno4bU16OVRjWldnOE1HVVdTMUcyaEpsSHl0QnN3Z2otZGwtald3V2RSQ2R0TW5UT3FKYkJnTFNBVzBCSk1KZEhKZHNvN2ZfU1c2d1VjR0w3dQ?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T00:39:38+00:00", "published_display": "08 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics (DMRA) GC\u2019s RSU vesting triggers 245-share tax sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcU94aFR6aXgyR2VpcTl5QzFkWGt2cTNIcDFjM1gyM051X0R2OERhWF9xUHlJOGI2WGlXT1BXRHpqbmVpeHV1Z1hEVlpPZEpkVG1CVU9qY2xhTW9sQzhEQmlOUDdXWllsdm9qNGNzS1ZOVWhORi1mWFFiUEdYT2VqV0lxejJUMTliM2M3R1A5bGlmT3JQWVEwQTlMMFBQV1paMS1yNUppMFpZWjNnc3R4bGZybWVYTTkz?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics (DMRA) Joins Russell Indexes With Valuation Still Looking About Right", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Damora Therapeutics, Inc. \u2013 NASDAQ:DMRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPTmdUSWxhbjNtWG8zNEE1N2ptRXlIMFpyN0tuQ3dEcTlGTmxCclR3N3BXRVUwX3pfbElGb0dNQTVtMDZLbEZhdDBVdjZqY09ZeTVjeGlMWUdqRjVYQkNDODJCeDlod1JnS25KOU0tM1lHanFaMEhBZnFNN19hUHRoVVY3RHBRQVpoZmxhSk10c0N6aUlDTHQzREdIVHRZYlpmLUE?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T02:04:33+00:00", "published_display": "05 Jul 2026 02:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/damora-therapeutics-announces-inducement-grants-200100606.html", "source_name": "GlobeNewswire", "published_at": "2026-07-01T20:01:00+00:00", "published_display": "01 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora awards 453,500 stock options to nine new hires", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNVVJhN2NRZ3I3aE15Y3pNTUU2aUo0ZERndDNZRkc1enRRNkc3bmdQWWpMUThGZVY4WDJiLV9pdm8yejFJZFVPSGFTWno2ODVtX210Mlo3aFptQmJDY0Noc0RoRzZNbE5fTDFvRl83eG13M0FORzgtb3paU25PeGM2QTJWMG8yZ1R1MmxnanNyQmx6Zmw0OGFEQ1JuNEVmM2xsR1hOUG1nNUh3TTRZZUI4RW9iWVEzaHNHZl9ENzZ4Yzk?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics Rises as Traders Focus on Near-Term Pipeline Catalysts | DMRA Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYW90SEY1N1JyLWFaMHBvTU1Ib1dfMW1kbXk1Qjc0djhnNUlyb20wQ2hKVmJLcXl4VWNuMmpGQU43ZVJwdmdBVkUxQjIxNUxpUWZ4cTVsSHRzYTJoOVhLQndsYVh0dGpRcEJtdjJtNEdmS3hkSjZVQlJnaFkzUFZRclQ0eDI4czR0SE8xWW5JNG1KXzF0Z2NfYllNUFdCVFd0VlpITHRfdXlNdkE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HC Wainwright Initiates Damora Therapeutics at Buy With $45 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/hc-wainwright-initiates-damora-therapeutics-103943155.html", "source_name": "MT Newswires", "published_at": "2026-06-11T10:39:43+00:00", "published_display": "11 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TD Cowen Initiates Damora Therapeutics at Buy", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/td-cowen-initiates-damora-therapeutics-102031784.html", "source_name": "MT Newswires", "published_at": "2026-06-08T10:20:31+00:00", "published_display": "08 Jun 2026 10:20", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Six new Damora hires get 372,000 stock options in Nasdaq inducement grants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPaEpjTlNGbXpMV3lZcUNBMGdkbnBLc3NFRUlWSWItVjZsWFptVVZXaXdBTEtwZkxTSWp5aXVkYUxlcmU1RldyS2VCamxpMTZpdXF5ZEpWRnVJSGxOdkV0NkV5SmRvVnJWMTNaTEFHcHc0TWdUU3d6Q2NyZFhmaDM0eXM0cm9Hd0hvN0dRcURVR0VCMndhNTBpU3lXUlF5eXZTWlgyWEFUbVdsR1hMcjUwZE8zUmlYWm5udEplNnNBazA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge", "summary": "", "url": "https://finance.yahoo.com/m/d49ea2e2-4c01-3fbc-8219-76f9476b234a/why-this-fund-made-a-%2466.html", "source_name": "Motley Fool", "published_at": "2026-05-30T18:12:32+00:00", "published_display": "30 May 2026 18:12", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wedbush Initiates Damora Therapeutics at Outperform With $35 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wedbush-initiates-damora-therapeutics-outperform-114542024.html", "source_name": "MT Newswires", "published_at": "2026-05-28T11:45:42+00:00", "published_display": "28 May 2026 11:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights", "summary": "", "url": "https://finance.yahoo.com/news/damora-therapeutics-reports-first-quarter-200500669.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T20:05:00+00:00", "published_display": "12 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "What Damora Therapeutics (DMRA)'s CEO Shake-Up and Finance Refresh Means For Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOSV9LWDJDRXk0WVZXNklMQkVDVm1ZeFlYTXRvT3NqT0l0UmZTTWV0c0lXcnZFMGwxRWFXUUNzc281VEVQLXQ1LVR3Y2s2X1Z1clRxeFNYZEg1VElRcWJtN3o1MUh1Z3BJUzl1S3ExTGkxTHk3WmotRUFBbHdHVEJQRjNOajE5dWhFaFBHU21JNnhqVFhPVWhzWk82dmloVzJa?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics (DMRA) Appoints Jennifer Jarrett as President, Chief Executive Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/damora-therapeutics-dmra-appoints-jennifer-170519713.html", "source_name": "Insider Monkey", "published_at": "2026-05-05T17:05:19+00:00", "published_display": "05 May 2026 17:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Damora Therapeutics (DMRA) Valuation After CFO Transition And Recent Share Price Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNVE1CVGM5QktKY0I5LVZSUldaRDRBLWtGMUNvZzFYaG14eWQ3R09STWNwNTZQUlFzalNtM2xsMzJtckxhcldoU1ZYbnBJVUJpNW5vbUYxMFJjbXB6bzJwR19OUHh6c3E1cjdTejZkMzBkTUVhd1Zqc2puRUNaVC1UckJfYUhhU3lFaXhRZ0txMkN2NVdfY1gzU3hwakhWOGQ3SzctSndyN0RCdzc1NEE?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "DAMORA THERAPEUT (DMRA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5oUHlGeVZxbVlwZDd4eU5YRzdlUG1SMlFva2FMZ2Z1MkZnT3ZFZzdGbmU4TjFhX3dLdjZCaGJHUWh6RjB6QzYtVldrc2ZrdXJCZ05B?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-19T20:12:32+00:00", "published_display": "19 Mar 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics, Inc. Common Stock (DMRA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBLd2hoeHFiQUZudUZvN2FTRmdXd0M0aGdPN09WZ3hQT2lWWDFSeFAzRXFKcDdtQXVOalRFQ1dzLTdxcHkxcmdLV0Q5VS1Td28xcU5pbU84TEV1dw?oc=5", "source_name": "MarketBeat", "published_at": "2026-03-19T05:09:29+00:00", "published_display": "19 Mar 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics, Inc. Common Stock (DMRA) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE84WUVEajkxdXZrSGlNc2pZb0hsWkZXcTJNd3NOMWh2MkJ5TFMzY1NFR2pZS09wRFFHSW1fc0x2RGdlUFYycVZ5YWNtdU12aF9fSGR6bmVKR08ta3BFVDNiRDMxdW43UQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-03-19T05:06:14+00:00", "published_display": "19 Mar 2026 05:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DMRA Stock Price and Chart \u2014 NASDAQ:DMRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9VaFJKdkVIeUdwajJZMUE0OWhMODdMUXBUZGh5MXpSM3lyZGZPQkdWNlExcFRYS3ZycW5lMmdWbm1zX21WNzI5bjZHSTU0ODJzSHFnTFFpZU1jajlz?oc=5", "source_name": "TradingView", "published_at": "2026-03-10T16:05:12+00:00", "published_display": "10 Mar 2026 16:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics holds $535M cash to target rare blood cancers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWEpGc1Q1Y0h5Sm0wT3NrWWFjTkdMYmNTM2J1Ql8ydENnemxoX1FjTHpEWnJNRU1sdGVadmRoZmNSMlB1M1gtNUVqeFZtdXhQUEhHc1d6bmZtYTRxOW41RzZ3bXZzWUt2SlRuVTZPQVlVWlBEeDB2TmV6aUZaUTdBNUtJN0Qwd2JrV1JiMlBvZUNzQ01qVW1tZmVHN2d6Q2xxSzVWRWx5VHljTlJjS0RWZGtIS2ZTY3RlZ290M1Fqel8?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Galecto rebrands as Damora Therapeutics, begins Nasdaq trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQNzEzR0xjVVg3aUVrd3pNTkhhQWVRTTZDWmZHWUlfMkVvbDF2eGgtLVk5dWVnWm9lSUJ2Ni1Vbk5JR3NRQmFEOGNvMXhCRWh4azlFMi1RTkxaU0V3eWV0N0JieGZ4T0xCQmZseGY5OTdKU1IwMHNIRzhXM05lSnpoalNJWkkyTkgxX1p6R0FQOFdzX2Q1NmtSdW5pbWpOVUdtVE9TSG5mYjBOUWdDOEhheHU4czJpY3I0NEE?oc=5", "source_name": "Investing.com", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Galecto Announces Acquisition of Damora Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQN0ZqZ0VyQnRMUkhaUk9HMGhZNjFuRldzSVhrSEl4dFk5N1duSjgxMEF2X1hrUnotVXdCdmxrY25NVkF4Z2hUbFU1VHJyWUZRTlVuc3g5QlRZT1dzRmxmLWxEYl9zcXQ5dFI3UjJsNUQzUGFoS21rQ25lZThOajJkNmd3YkdvaExCNVZHUHlGcmVvRmt1eUZncldpVQ?oc=5", "source_name": "Market source", "published_at": "2025-11-10T08:00:00+00:00", "published_display": "10 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "H.C. Wainwright reiterates Buy on Damora Therapeutics stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQclF3SS1sMkVCZVpTRkZLUTVjenlqQXVnM1NTaFRiYTJhbFRiNmRSdExxd2E5cFQ4SnFyZ1BNZnJoVUlydmFraFdPSVRfQlZnbHFaeldsOFcza21FcVV2cXVsZU5Eb3h6TFBIQjhJT19FaTBYcnVVVDYxRkF6T1pMc0ZKbTdmWHdIbDF0bFhVcF93YjlBSk1MY0RnTnhtbnM5WktvcmZTc29wOE1uSS1LbWpXcUc2bGM1?oc=5", "source_name": "Investing.com", "published_at": "2026-07-21T11:59:16+00:00", "published_display": "21 Jul 2026 11:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics, Inc. Common Stock (DMRA) Stock Trends and Sentiment 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE5BdzA0NGc0bnVWZy1yaGxjWE02VG53ZkFXUE5xSmpWRVM1VndyVVU0SWFlVGJmOXA2dVNFOWpzcVdFOWxfaHRMQmFsNUJRNml5RU1nTlNKLVJfMEphRC12Z0U4QWM0TXJWNUZ6X1puZnlrdkk2dlE?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-19T16:26:59+00:00", "published_display": "19 Jul 2026 16:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNTUcwY1FLazBFeUZjY3dIN0JtNnBZcVdUNGhUX3RBTlBfYTJ2elBCeV9NRmw0d1lndzZWWlB6ZDMtYXlnY1FaZnRyYWRyYzVzQ3AzcF9Jd1dlU29xM3lyLWo4MlItVm4zNFc2dVVfM1JPY1FoRk52VWZVb2ZxcVpfcw?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-19T14:58:42+00:00", "published_display": "19 Jul 2026 14:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics Completes Redomestication to Cayman Islands", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/damora-therapeutics-completes-redomestication-cayman-172646630.html", "source_name": "MT Newswires", "published_at": "2026-07-17T17:26:46+00:00", "published_display": "17 Jul 2026 17:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics completes redomestication to Cayman Islands By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNNUNJbERXN3A2aUd1NGhBaEJTd0ZTNE4zeTVXQXI4dEJaU2RNTS0wTWppR1VjNGFUMGJHY1Z4RjNfN3BEY2FDdTRpT1VKbWIzQkgxX2Y0cGFuUGdpWl9FSVVudEdqQktvS0xJWUF0VVkxZ1RXRDFjY3hubWE2a1NvTXFtbXFNUF9Bckota0pUemZBeEVwbFBoTHhOaU52SVZfbW5rLUtrQ1RUMUR3OUZVaEZmMmlEdXJxYWhfMnAxLTVodw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-17T13:02:37+00:00", "published_display": "17 Jul 2026 13:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Announces Redomestication from Delaware to Cayman Islands", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxOWmprSDg3LVN0MF84N1ItLWItaEpCOHctQU9lWmk4dHM3UklxMF8tby1mZGpEVGFyVml4SThsd01XM2J3cndkQkh1YXRXcGhGazBONUFnRUNIMTJGMUtiZlN4eV9lRXo5TEU0OGJCM1FOdE1IS1BNWW8wN3JFVXBfX2NZNlZQTU9oTDRBakpJMV94akxaazFXNGM3ZnJzRFVQaC1sS0Nkb3RUTExsQUxHWTVHYXAtVzkta2pmLThETFJ3SmlOYWt0UVVnR1lqY0x6ZDFDeNIB2gFBVV95cUxQSmYwcm0wWmF5UmFodWl4R21Uck04SkZ2MFdJd25pZjZQV2R0cmF6QW9MMlJ5TjhUd05yN1ppT29KQnN2eUYtNVpFS3ljb29wazRrYjVoQVlRVS1DbEtYMnc5QlFqeUdYWXgtWS1rSUp0aGpBdnhmX0M4ZUVZWmh5S1ZHVTJjM1ljNldfTXhobC1pb2hjcUJQWUlhUy14VGpqQk5DOE83UzNwRnBHdnJiRGphdk5pUEhwU29WRWEwUUVrUElYLXNNOFdtWUlFM01RRG1raGgxbXZuZw?oc=5", "source_name": "The Manila Times", "published_at": "2026-07-17T12:13:40+00:00", "published_display": "17 Jul 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Will Keep DMRA Ticker Under New Nasdaq CUSIP July 20", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQeW5iaVZadVE3Wkp3all5eUEwSlE4RGRBRzdHRmNlc1BfU2otU3lhZHp4VWtRcFV1UGc0LUxQV0JJRzlKb3diM0FxSllzVm1SbHZHZmFtb3NXRjBxX3VXeWtuT2Y0UTVFN1djU0NyTEpZbzlsZlFWLXBGQk55TzBMWWpIVXFqb1BfaUdvRHpRMkhIOVJnU2xKVTJoWDRqNG9OYm5DeUlxMUh6blE3dVNYQg?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-17T12:00:00+00:00", "published_display": "17 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Damora Therapeutics Inc For: 7 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNMmhydlNGaDVPajJDYTZCLUNfQjNsc3ZyZU9Zb192bTZKazFtcGRIaVJRWXFQay1ERnVNNmtGbmU1Q1JTTGZTYUlXRVRlOGFuSGI5eno4bU16OVRjWldnOE1HVVdTMUcyaEpsSHl0QnN3Z2otZGwtald3V2RSQ2R0TW5UT3FKYkJnTFNBVzBCSk1KZEhKZHNvN2ZfU1c2d1VjR0w3dQ?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T00:39:38+00:00", "published_display": "08 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics (DMRA) GC\u2019s RSU vesting triggers 245-share tax sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcU94aFR6aXgyR2VpcTl5QzFkWGt2cTNIcDFjM1gyM051X0R2OERhWF9xUHlJOGI2WGlXT1BXRHpqbmVpeHV1Z1hEVlpPZEpkVG1CVU9qY2xhTW9sQzhEQmlOUDdXWllsdm9qNGNzS1ZOVWhORi1mWFFiUEdYT2VqV0lxejJUMTliM2M3R1A5bGlmT3JQWVEwQTlMMFBQV1paMS1yNUppMFpZWjNnc3R4bGZybWVYTTkz?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics (DMRA) Joins Russell Indexes With Valuation Still Looking About Right", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPV3RpVElLOHYtc0tKakRkbzFfbW56XzNhZGNxRTAwQk9hYzRndi0zLURKNzJ6TjFWcXZHWnZnOXpHOE8ta1lLa2pVQXRINl9XWEhQZGxGczZ2eG5Hb3RSMEFQRERyTktHZzhJVVprVVRMMjFnWWRNYzg5V3hQVlpnbzN5WmdIU1JmQWx0c3hIVW5CaGZhRmFLMkdiMlYyWjcxYUNGYlMxaFVRUThTTDVhdVE3bHlkZjR6V3ZIZVZkMjZUSmh0WlJkM21nVVk3VlU1RXo4MGNDSGR2TGtnMzl5Q1BYajZPRU5a0gHuAUFVX3lxTE9MR0xsSTFHYzZJZ1AxZkRRMVRFbkNtUXZFOXQwcm43aE9ibFBqSGNsbGp5RUxjYmJuUkF6dmFJUGFZeno5MWVyVmFITzZMLUtlSWxDaklORC1WLVBoNHpZcTFWcjVNb3E5ZnVKNl9FalZlU0pXc29MNDFVQWRVOHNHVEc4TGVEYmhOZnJBRU1JZk96dTJVd1JYVVd4aGZzVmhjR3hUekIzNGlzVDVyR3hoYmxGQ2xHQnFidEVreGluODN4UmVXVEMxNHE3YzljQ0FUcW9wQ2NkNk1VQ1ZVeF9ReVlaSEd3WHFHOVJFdHc?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Damora Therapeutics, Inc. \u2013 NASDAQ:DMRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPTmdUSWxhbjNtWG8zNEE1N2ptRXlIMFpyN0tuQ3dEcTlGTmxCclR3N3BXRVUwX3pfbElGb0dNQTVtMDZLbEZhdDBVdjZqY09ZeTVjeGlMWUdqRjVYQkNDODJCeDlod1JnS25KOU0tM1lHanFaMEhBZnFNN19hUHRoVVY3RHBRQVpoZmxhSk10c0N6aUlDTHQzREdIVHRZYlpmLUE?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T02:04:33+00:00", "published_display": "05 Jul 2026 02:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/damora-therapeutics-announces-inducement-grants-200100606.html", "source_name": "GlobeNewswire", "published_at": "2026-07-01T20:01:00+00:00", "published_display": "01 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora awards 453,500 stock options to nine new hires", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNVVJhN2NRZ3I3aE15Y3pNTUU2aUo0ZERndDNZRkc1enRRNkc3bmdQWWpMUThGZVY4WDJiLV9pdm8yejFJZFVPSGFTWno2ODVtX210Mlo3aFptQmJDY0Noc0RoRzZNbE5fTDFvRl83eG13M0FORzgtb3paU25PeGM2QTJWMG8yZ1R1MmxnanNyQmx6Zmw0OGFEQ1JuNEVmM2xsR1hOUG1nNUh3TTRZZUI4RW9iWVEzaHNHZl9ENzZ4Yzk?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics Rises as Traders Focus on Near-Term Pipeline Catalysts | DMRA Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYW90SEY1N1JyLWFaMHBvTU1Ib1dfMW1kbXk1Qjc0djhnNUlyb20wQ2hKVmJLcXl4VWNuMmpGQU43ZVJwdmdBVkUxQjIxNUxpUWZ4cTVsSHRzYTJoOVhLQndsYVh0dGpRcEJtdjJtNEdmS3hkSjZVQlJnaFkzUFZRclQ0eDI4czR0SE8xWW5JNG1KXzF0Z2NfYllNUFdCVFd0VlpITHRfdXlNdkE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HC Wainwright Initiates Damora Therapeutics at Buy With $45 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/hc-wainwright-initiates-damora-therapeutics-103943155.html", "source_name": "MT Newswires", "published_at": "2026-06-11T10:39:43+00:00", "published_display": "11 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TD Cowen Initiates Damora Therapeutics at Buy", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/td-cowen-initiates-damora-therapeutics-102031784.html", "source_name": "MT Newswires", "published_at": "2026-06-08T10:20:31+00:00", "published_display": "08 Jun 2026 10:20", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Six new Damora hires get 372,000 stock options in Nasdaq inducement grants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPaEpjTlNGbXpMV3lZcUNBMGdkbnBLc3NFRUlWSWItVjZsWFptVVZXaXdBTEtwZkxTSWp5aXVkYUxlcmU1RldyS2VCamxpMTZpdXF5ZEpWRnVJSGxOdkV0NkV5SmRvVnJWMTNaTEFHcHc0TWdUU3d6Q2NyZFhmaDM0eXM0cm9Hd0hvN0dRcURVR0VCMndhNTBpU3lXUlF5eXZTWlgyWEFUbVdsR1hMcjUwZE8zUmlYWm5udEplNnNBazA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge", "summary": "", "url": "https://finance.yahoo.com/m/d49ea2e2-4c01-3fbc-8219-76f9476b234a/why-this-fund-made-a-%2466.html", "source_name": "Motley Fool", "published_at": "2026-05-30T18:12:32+00:00", "published_display": "30 May 2026 18:12", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wedbush Initiates Damora Therapeutics at Outperform With $35 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wedbush-initiates-damora-therapeutics-outperform-114542024.html", "source_name": "MT Newswires", "published_at": "2026-05-28T11:45:42+00:00", "published_display": "28 May 2026 11:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights", "summary": "", "url": "https://finance.yahoo.com/news/damora-therapeutics-reports-first-quarter-200500669.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T20:05:00+00:00", "published_display": "12 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Damora Therapeutics (DMRA)'s CEO Shake-Up and Finance Refresh Means For Shareholders", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOSV9LWDJDRXk0WVZXNklMQkVDVm1ZeFlYTXRvT3NqT0l0UmZTTWV0c0lXcnZFMGwxRWFXUUNzc281VEVQLXQ1LVR3Y2s2X1Z1clRxeFNYZEg1VElRcWJtN3o1MUh1Z3BJUzl1S3ExTGkxTHk3WmotRUFBbHdHVEJQRjNOajE5dWhFaFBHU21JNnhqVFhPVWhzWk82dmloVzJa?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics (DMRA) Appoints Jennifer Jarrett as President, Chief Executive Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/damora-therapeutics-dmra-appoints-jennifer-170519713.html", "source_name": "Insider Monkey", "published_at": "2026-05-05T17:05:19+00:00", "published_display": "05 May 2026 17:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Damora Therapeutics (DMRA) Valuation After CFO Transition And Recent Share Price Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNVE1CVGM5QktKY0I5LVZSUldaRDRBLWtGMUNvZzFYaG14eWQ3R09STWNwNTZQUlFzalNtM2xsMzJtckxhcldoU1ZYbnBJVUJpNW5vbUYxMFJjbXB6bzJwR19OUHh6c3E1cjdTejZkMzBkTUVhd1Zqc2puRUNaVC1UckJfYUhhU3lFaXhRZ0txMkN2NVdfY1gzU3hwakhWOGQ3SzctSndyN0RCdzc1NEE?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DAMORA THERAPEUT (DMRA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5oUHlGeVZxbVlwZDd4eU5YRzdlUG1SMlFva2FMZ2Z1MkZnT3ZFZzdGbmU4TjFhX3dLdjZCaGJHUWh6RjB6QzYtVldrc2ZrdXJCZ05B?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-19T20:12:32+00:00", "published_display": "19 Mar 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics, Inc. Common Stock (DMRA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBLd2hoeHFiQUZudUZvN2FTRmdXd0M0aGdPN09WZ3hQT2lWWDFSeFAzRXFKcDdtQXVOalRFQ1dzLTdxcHkxcmdLV0Q5VS1Td28xcU5pbU84TEV1dw?oc=5", "source_name": "MarketBeat", "published_at": "2026-03-19T05:09:29+00:00", "published_display": "19 Mar 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics, Inc. Common Stock (DMRA) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE84WUVEajkxdXZrSGlNc2pZb0hsWkZXcTJNd3NOMWh2MkJ5TFMzY1NFR2pZS09wRFFHSW1fc0x2RGdlUFYycVZ5YWNtdU12aF9fSGR6bmVKR08ta3BFVDNiRDMxdW43UQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-03-19T05:06:14+00:00", "published_display": "19 Mar 2026 05:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DMRA Stock Price and Chart \u2014 NASDAQ:DMRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9VaFJKdkVIeUdwajJZMUE0OWhMODdMUXBUZGh5MXpSM3lyZGZPQkdWNlExcFRYS3ZycW5lMmdWbm1zX21WNzI5bjZHSTU0ODJzSHFnTFFpZU1jajlz?oc=5", "source_name": "TradingView", "published_at": "2026-03-10T16:05:12+00:00", "published_display": "10 Mar 2026 16:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Damora Therapeutics holds $535M cash to target rare blood cancers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWEpGc1Q1Y0h5Sm0wT3NrWWFjTkdMYmNTM2J1Ql8ydENnemxoX1FjTHpEWnJNRU1sdGVadmRoZmNSMlB1M1gtNUVqeFZtdXhQUEhHc1d6bmZtYTRxOW41RzZ3bXZzWUt2SlRuVTZPQVlVWlBEeDB2TmV6aUZaUTdBNUtJN0Qwd2JrV1JiMlBvZUNzQ01qVW1tZmVHN2d6Q2xxSzVWRWx5VHljTlJjS0RWZGtIS2ZTY3RlZ290M1Fqel8?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Galecto rebrands as Damora Therapeutics, begins Nasdaq trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQNzEzR0xjVVg3aUVrd3pNTkhhQWVRTTZDWmZHWUlfMkVvbDF2eGgtLVk5dWVnWm9lSUJ2Ni1Vbk5JR3NRQmFEOGNvMXhCRWh4azlFMi1RTkxaU0V3eWV0N0JieGZ4T0xCQmZseGY5OTdKU1IwMHNIRzhXM05lSnpoalNJWkkyTkgxX1p6R0FQOFdzX2Q1NmtSdW5pbWpOVUdtVE9TSG5mYjBOUWdDOEhheHU4czJpY3I0NEE?oc=5", "source_name": "Investing.com", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Galecto Announces Acquisition of Damora Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQN0ZqZ0VyQnRMUkhaUk9HMGhZNjFuRldzSVhrSEl4dFk5N1duSjgxMEF2X1hrUnotVXdCdmxrY25NVkF4Z2hUbFU1VHJyWUZRTlVuc3g5QlRZT1dzRmxmLWxEYl9zcXQ5dFI3UjJsNUQzUGFoS21rQ25lZThOajJkNmd3YkdvaExCNVZHUHlGcmVvRmt1eUZncldpVQ?oc=5", "source_name": "Market source", "published_at": "2025-11-10T08:00:00+00:00", "published_display": "10 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 73, "total_relevant": 39, "sentiment_summary": {"positive": 6, "negative": 1, "neutral": 32, "score": 52, "total": 39, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 12.65, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 4.81, "count": 11}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 31.48, "latest_week": "2026-07-17", "one_week_move": 10.3, "four_week_move": 48.3, "twelve_week_move": 27.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.342549, "market_dynamics_buy_signal": false, "relative_strength": 49.91798, "fair_value_gap": 112.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 43.18, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+10.3% over one week, +48.3% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "Stock Titan", "count": 6}, {"label": "MarketBeat", "count": 4}, {"label": "MT Newswires", "count": 4}, {"label": "simplywall.st", "count": 3}, {"label": "TradingView", "count": 3}, {"label": "Investing.com", "count": 2}, {"label": "Investing.com Nigeria", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 30}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Earnings", "count": 11}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "30", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+10.3% over one week, +48.3% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "H.C. Wainwright reiterates Buy on Damora Therapeutics stock"}], "updated_at": "2026-07-21T20:43:20.592734+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}